Clinical Evidence Comparing Wegovy vs Mounjaro Results
What's Best Wegovy or Mounjaro: Understanding the Clinical Evidence
When determining what's best between Wegovy or Mounjaro, clinical trial data provides the foundation for informed decisions. Wegovy's evidence base centres on the comprehensive STEP trial programme, demonstrating consistent weight management outcomes across diverse patient populations. The STEP 1 trial showed patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). These results represent some of the most robust weight management data available for prescription treatments.
Mounjaro's clinical profile emerges from the SURMOUNT trials, showcasing the dual GIP and GLP-1 receptor agonist mechanism. However, direct comparison between trial results isn't clinically meaningful due to different study designs, patient populations, and endpoints. What's best for Wegovy or Mounjaro ultimately depends on individual factors including tolerance, medical history, and treatment response. Both medications require prescription from qualified healthcare professionals who can assess suitability based on your specific circumstances.
Wegovy vs Mounjaro Pricing and Value at EverydayMeds
Understanding what's best between Wegovy or Mounjaro includes evaluating cost and accessibility. At EverydayMeds, Wegovy pricing starts with the 0.25mg dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance 2.4mg (£209.99). Our bundle options provide convenience for ongoing treatment, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25.
Both Wegovy and Mounjaro are available through our streamlined ordering process, ensuring you have options when deciding what's best. Our bundles offer supply security rather than savings—the Progress Trio provides three months of step-up dosing for £369.99, eliminating multiple orders and ensuring treatment continuity. Transparent pricing means no hidden costs, with all fees included in the listed prices. This approach helps you plan your weight management investment whether choosing Wegovy or exploring Mounjaro alternatives.
Clinical Trial Results: What Makes Wegovy Effective
The STEP trial programme provides compelling evidence for Wegovy's efficacy when determining what's best between Wegovy or Mounjaro. STEP 3 demonstrated approximately clinically studied weight loss when Wegovy was combined with intensive behavioural therapy, whilst STEP 5 showed sustained clinically studied weight loss maintained at two years. The recent SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, expanding Wegovy's clinical value beyond weight management.
These results occurred alongside reduced-calorie diet and increased physical activity, emphasising that medication forms part of comprehensive lifestyle modification. When considering what's best for Wegovy or Mounjaro, remember that individual responses vary, and clinical trials represent average outcomes across large patient groups. Your prescriber will evaluate your medical history, current medications, and weight management goals to determine the most appropriate treatment approach.
How Wegovy Works: The GLP-1 Mechanism Explained
Understanding what's best between Wegovy or Mounjaro requires knowing how each medication functions in your body. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics naturally occurring hormones regulating appetite and blood glucose. This mechanism reduces appetite by acting on brain centres controlling hunger and satiety, helping you feel fuller after smaller meals. The once-weekly injection provides consistent medication levels, supporting sustained appetite control throughout your treatment journey. Unlike Mounjaro's dual GIP and GLP-1 action, Wegovy focuses specifically on GLP-1 pathways, offering a targeted approach to weight management that has been extensively studied in clinical settings.
EverydayMeds Ordering Process: From Assessment to Delivery
Accessing Wegovy through EverydayMeds begins with our 3-minute online clinical assessment, designed to gather essential medical information for prescriber review. Our qualified prescribers, operating under GPhC registration #9012878, evaluate your assessment within three working days (or 24 hours with express service). Once approved, your prescription-only medicine ships via next-day delivery using professional cold-chain handling to maintain medication integrity. This streamlined process ensures you receive genuine Wegovy from our MHRA-regulated pharmacy, eliminating concerns about product authenticity. The entire journey from assessment to receiving your FlexTouch pen typically takes under a week, providing rapid access to clinically proven weight management support.
Storage and Practical Considerations for Wegovy Treatment
Practical factors influence what's best when choosing between Wegovy or Mounjaro, particularly regarding storage requirements and administration. Wegovy requires refrigeration at 2-8°C before first use but maintains stability for six weeks at room temperature below 30°C once removed from the fridge. This storage flexibility provides significant advantages over Mounjaro's 21-day room temperature limit, making Wegovy more suitable for travel or varying lifestyle demands. The FlexTouch pen delivers pre-measured doses subcutaneously once weekly, with mandatory dose escalation from 0.25mg through to 2.4mg maintenance. Each dose increase occurs over four-week periods, allowing your body to adjust gradually whilst minimising potential side effects during treatment initiation.
What's Best Wegovy or Mounjaro: Comparing Treatment Profiles
The question of what's best between Wegovy or Mounjaro cannot be answered universally, as optimal treatment varies among individuals based on medical history, tolerance, and treatment goals. Wegovy's single GLP-1 receptor action provides a well-established mechanism with extensive clinical data, whilst Mounjaro's dual GIP and GLP-1 approach offers a different therapeutic pathway. Both medications are prescription-only medicines requiring ongoing medical supervision and lifestyle modification including reduced-calorie diet and increased physical activity.
Your prescriber will consider factors including existing medical conditions, current medications, previous weight management attempts, and personal preferences when determining what's best. Some patients may respond more favourably to Wegovy's mechanism, whilst others might benefit from Mounjaro's dual action. Both treatments are available at EverydayMeds with the same professional prescriber oversight and delivery standards, ensuring you receive appropriate ongoing support regardless of which option proves most suitable for your circumstances.
Making Your Decision: Expert Guidance at EverydayMeds
Determining what's best between Wegovy or Mounjaro requires professional medical guidance rather than self-selection based on marketing claims or anecdotal experiences. At EverydayMeds, our clinical team holds extensive experience with both treatments, enabling informed recommendations based on your individual assessment. Begin with our straightforward online consultation, applying discount code FIRST40 as a new customer or DOSE25 for returning patients. Our prescribers will review your medical history, discuss treatment expectations, and explain the evidence supporting each option. Whether you ultimately receive Wegovy or Mounjaro, ongoing prescriber support ensures treatment safety and optimises your weight management outcomes through our GPhC-registered pharmacy service.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
